HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Transforming growth factor-beta1 levels in hypertensive patients: association with body mass index and leptin.

AbstractBACKGROUND:
Transforming growth factor-beta1 (TGF-beta1) has been demonstrated to be overexpressed in hypertension. Leptin, an adipocyte product, has been shown to play a role in obesity-related hypertension and in vitro studies demonstrated a biologic interaction between leptin and TGF-beta1. Thus, we evaluate a possible in vivo association between TGF-beta1, body mass index (BMI), and leptin circulating levels in hypertensive subjects.
METHODS:
Blood samples for fasting leptin and TGF-beta1, were evaluated in 29 overweight, 46 obese, and 29 nonobese hypertensive patients before and after a 12-week calorie-restricted diet. Monocyte cultures were used for in vitro experiments.
RESULTS:
Transforming growth factor-beta1 was significantly elevated in hypertensive obese patients (n = 46) as compared with TGF-beta1 levels of hypertensive patients with normal BMI (n = 29) (8. 9 +/- 3 ng/mL v 4.4 +/- 2; P < .001). The circulating levels of TGF-beta1 were associated with BMI and leptin levels in an univariate analysis (r = 0.59, P < .0001; r = 0.62, P < .0001, respectively) and these associations were still present after stepwise multivariate analysis. Weight loss of 10% produced a parallel decrease in TGF-beta1 (from 8.9 +/- 3 ng/mL to 5.3 +/- 2.8 ng/mL; P < .01) and leptin levels (from 30 +/- 24 ng/mL to 17 +/- 14; P < .05). In vitro experiments showed that leptin is able to induce a dose-dependent increase in TGF-beta1 production and mRNA expression in human monocyte cultures.
CONCLUSIONS:
Our data indicate that TGF-beta1 levels are positively associated with BMI and leptin levels in hypertensive patients and suggest that adipose tissue may be an important determinant of TGF-beta1 levels possibly by a leptin-dependent pathway.
AuthorsEttore Porreca, Concetta Di Febbo, Ester Vitacolonna, Giovanna Baccante, Augusto Di Castelnuovo, Antonio Angelini, Francesca Febo, Marcello Di Nisio, Franco Cuccurullo
JournalAmerican journal of hypertension (Am J Hypertens) Vol. 15 Issue 9 Pg. 759-65 (Sep 2002) ISSN: 0895-7061 [Print] United States
PMID12219869 (Publication Type: Evaluation Study, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Leptin
  • RNA, Messenger
  • Transforming Growth Factor beta
Topics
  • Adult
  • Blood Pressure (physiology)
  • Body Mass Index
  • Female
  • Gene Expression (genetics)
  • Humans
  • Hypertension (blood, complications, physiopathology)
  • In Vitro Techniques
  • Leptin (blood)
  • Male
  • Middle Aged
  • Obesity (blood, complications, physiopathology)
  • RNA, Messenger (genetics)
  • Regression Analysis
  • Transforming Growth Factor beta (blood, genetics)
  • Weight Loss (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: